Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06356168 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Virtual Reality in End Stage Kidney Disease

StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Final enrollment: 54 participants (planned 60) · Study completion date changed from estimate of Dec 31, 2026 to Aug 15, 2026 · Site details revised · 1 more Show 4 more changesShow less
    • Final enrollment: 54 participants (planned 60)
    • Study completion date changed from estimate of Dec 31, 2026 to Aug 15, 2026
    • Site details revised
    • Eligibility criteria expanded, about 4 words
  2. Primary completion pushed from May 31, 2026 to Aug 31, 2026 Completion pushed from Jul 31, 2026 to Dec 31, 2026v8 Show 1 more changeShow less
    • Completion pushed from Jul 31, 2026 to Dec 31, 2026
  3. Trial status: Not Yet Recruiting to Recruiting Primary completion date: May 31, 2027 to May 31, 2026 · Study sites: 0 to 1 · Completion date: May 31, 2027 to Jul 31, 2026 · 1 morev7 Show 4 more changesShow less
    • Primary completion date: May 31, 2027 to May 31, 2026
    • Study sites: 0 to 1
    • Completion date: May 31, 2027 to Jul 31, 2026
    • Start date changed from estimate of Jan 15, 2026 to Mar 30, 2026
  4. Primary and study completion dates: May 31, 2025 to May 31, 2027 Start date: Jan 15, 2025 to Jan 15, 2026v6 Show 1 more changeShow less
    • Start date: Jan 15, 2025 to Jan 15, 2026
  5. Start date: Oct 1, 2024 to Jan 15, 2025 Primary completion date: Apr 30, 2025 to May 31, 2025v5 Show 1 more changeShow less
    • Primary completion date: Apr 30, 2025 to May 31, 2025
Show 3 earlier versionsHide 3 earlier versions
  1. Start date: Aug 1, 2024 to Oct 1, 2024 Primary completion date: Dec 31, 2024 to Apr 30, 2025 · Completion date: Jan 31, 2025 to May 31, 2025v4 Show 2 more changesShow less
    • Primary completion date: Dec 31, 2024 to Apr 30, 2025
    • Completion date: Jan 31, 2025 to May 31, 2025
  2. Start date: May 1, 2024 to Aug 1, 2024v3
  3. Eligibility criteria shortened, about 17 words Study description revisedv2 Show 1 more changeShow less
    • Study description revised

    See this version in full on ClinicalTrials.gov ↗

  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this clinical trial to compare the social virtual reality and individual virtual reality in patients with end stage kidney disease who are hemodialysis. The main aim is to determine if there are differences in symptoms between the groups. Participants will use virtual reality glasses for 30-45 minutes during dialysis sessions for 4 weeks.
Trial Details
NCT Number NCT06356168
Lead Sponsor University of Pennsylvania
Conditions End Stage Kidney Disease
Enrollment 54 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov